Found 5 matching trials
Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth Factor Receptor 3 (FGFR3) Altered Solid Tumors
N/AThe treating physician/investigator contacts Lilly when, based on their med...
Location
Multiple Locations
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
PHASE3The purpose of this study is to test a new medicine, vepugratinib, in compa...
Location
Clearview Cancer Institute
A Study of [14C]-LY3866288 in Healthy Participants
PHASE1The main purpose of this study is to evaluate how much of the study drug (L...
Location
Fortrea Clinical Research Unit
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
PHASE1The main purpose of this study is to learn more about the safety, side effe...
Location
University of Arizona - Cancer Center
A Study of LY3866288 in Healthy Participants
PHASE1The purpose of this study is to evaluate how well LY3866288 is tolerated an...
Location
Fortrea Clinical Research Unit